The results from the midterm elections have changed the political landscape of the U.S. House of Representatives and Senate. While some individual races remain to be called, the power shift in Congress has been confirmed: Democrats will take control of both the House of Representatives and the Senate. The next Congress, and the way it interacts with the Trump Administration on trade issues, will create new challenges and demand fresh strategies for companies. We share…
On October 23, 2026, President Trump issued a new proclamation — Further Modifying the Scope of Products of Canada Subject to the Additional Duties Imposed to Offset Canadian Discrimination Against the Commerce of the United States With Respect to Motor Vehicles — once again adjusting the list of Canadian-origin products subject to the 50% ad valorem duties imposed under Section 338 of the Tariff Act of 1930. The changes take effect for goods entered, or…
As US trade policy continues to evolve, businesses are increasingly confronting a reality in which tariffs are not simply temporary trade measures, but a recurring feature of the commercial landscape. This shift is prompting companies to incorporate tariff exposure into long-term decisions regarding sourcing, manufacturing, supply chain resilience and market access. At the same time, longstanding trade authorities and enforcement mechanisms are taking on renewed significance as policymakers use them to address economic, supply chain…
On September 8, 2026, the Government of Canada released the United States Surtax Order, 2026 (the 2026 Order), implementing Canada’s latest round of retaliatory tariffs on imports from the United States. The Canada Border Services Agency (CBSA) simultaneously issued Customs Notice 26-23, providing guidance on the administration of the new surtax regime. The measures contain several important compliance and operational considerations for Canadian importers, including confirmation that the existing remission framework has been extended to…
On August 25, 2026, the Government of Canada announced a new package of trade countermeasures and financial support programs in response to recent U.S. tariff actions. The announcement follows Canada’s decision to suspend trade negotiations with the United States after concluding that the latest U.S. proposals were not in Canada’s national interest. The new measures are a direct response to the United States’ decision to impose a 50% tariff on CAD 27.6 billion of Canadian…
The United States has imposed additional 50% duties on certain Canadian-origin imports pursuant to Section 338 of the Tariff Act of 1930, marking the first use of a rarely invoked authority in decades. The duties, which took effect on imported certain Canadian products entered or withdrawn from warehouse for consumption beginning at 12.01am Eastern Time on August 22, 2026 following a brief three-day suspension, target a broad range of Canadian products in response to alleged…
On August 13, 2026, the Trump Administration released a report announcing its focus on illegal transshipment, where goods allegedly enter the United States through intermediary jurisdictions to reduce or avoid otherwise applicable duties, as a customs enforcement priority. The announcement arrives amid a sustained enforcement focus from the Administration on tariff evasion. Our prior blog posts on the U.S. Department of Justice to actively investigate tariff evasion-related misconduct, and an Executive Order directing agencies to…
On August 6, 2026, President Trump issued a proclamation under Section 232 of the Trade Expansion Act of 1962, establishing new import restrictions on polysilicon and a range of downstream products. This is the result of a process that started in July 2025. The Administration concluded that increased reliance on foreign sources for these materials raises concerns over the resiliency of supply chains that support semiconductor manufacturing, solar technologies, defense applications, and other strategically important…
On July 30, 2026, the US Customs and Border Protection (“CBP”) issued implementation guidance for Section 232 tariffs on imports of patented pharmaceutical products and pharmaceutical ingredients, providing importers with reporting and classification instructions ahead of the tariffs’ effective dates. The guidance implements Presidential Proclamation 11020, issued on April 2, 2026, which imposes additional duties on certain patented pharmaceuticals and related active pharmaceutical ingredients and key starting materials. Generic pharmaceuticals and their associated ingredients remain…
On July 23, 2026, the Office of the U.S. Trade Representative (USTR) announced final and immediate new tariffs on imports from 60 economies (59 countries and the European Union), including nearly all of the United States’ largest trading partners. The duties are imposed under Section 301 of the Trade Act of 1974 and are tied to USTR’s assessment of measures these economies have taken to adopt and enforce prohibitions on the importation of goods made…